Loading
Latest filing published 12 Mar 2014 for SKYSTAR BIO-PHARMACEUTICAL CO.
No signal scores available.
Weibing Lu appears in our data through filings on Skystar Bio-Pharmaceutical Co shares, published by SEC (Form 4). Between 4 May 2012 and 10 March 2014, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 12 March 2014, the filings show a share grant in Skystar Bio-Pharmaceutical Co. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations